City of Hope
Dr. Saul Priceman is Associate Professor in the Departments of Hematology and Hematopoietic Cell Transplantation and Immuno-Oncology at City of Hope Comprehensive Cancer Center. He is also Associate Director of Translational Sciences in the T Cell Therapeutic Research Laboratories. Over the last 10 years, Dr. Priceman’s research has focused on T cell biology and clinical translation of cancer immunotherapies. His laboratory develops CAR based T cell therapies and combinatorial approaches for the treatment of solid cancers including breast, prostate, ovarian and pancreas, and has brought several therapies to phase 1 clinical testing. Dr. Priceman’s research has led to high-impact journal publications in Science Translational Medicine, Cell Metabolism, Clinical Cancer Research, and Molecular Therapy, with numerous patents and technologies licensed for further clinical development. His research has been funded with grants and/or awards from the NCI (R01 award), Department of Defense (DOD Idea Development award), California Institute for Regenerative Medicine (CIRM QUEST and CLIN2 awards), Prostate Cancer Foundation (PCF Young Investigator award, Challenge award, TACTICAL award), and the National Comprehensive Cancer Network (NCCN Young Investigator award). Dr. Priceman received his B.S. in microbiology at University of California Santa Barbara, his Ph.D. in molecular and medical pharmacology at University of California Los Angeles, and his postdoctoral research at City of Hope.
